BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
FDA Approves Plexxikon Drug
News | 10. 18. 2011
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.